Thursday, June 14, 2012
A team from Oregon Health & Science University and Najít Technologies Inc. has shown that hydrogen
peroxide could be a better way to inactivate
viral vaccines than conventional methods such as formaldehyde and b-propiolactone.1 Najít, which was spun out of the university
in 2004, hopes to start a Phase I trial of an inactivated yellow fever virus
vaccine in the next 1-2 years.
One pathogen at a time
Baas, T. SciBX 5(24);
Published online June 14, 2012
1. Amanna, I.J. et al. Nat. Med.; published online May 27, 2012; doi:10.1038/nm.2763
Contact: Mark K. Slifka, Oregon Health & Science
University, Beaverton, Ore.
2. Sykes, G. Disinfection and
Sterilization 9-37 (E. & F.N.
General Electric Co. (NYSE:GE), Fairfield, Conn.
Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J.
Najít Technologies Inc., Beaverton, Ore.
Novartis AG (NYSE:NVS; SWX:NOVN), Basel, Switzerland
Oregon Health & Science University, Beaverton, Ore.
(Euronext:SAN;NYSE:SNY), Paris, France